Skip to main content
24 August 2026
18 October 2023

GordonMD Announces Investment in Radiopharmaceutical Biotech Radionetics Oncology

Craig Gordon, MD, Chief Executive Officer of @GordonMD Global Investments LP, announced that his firm has jointly invested in a private placement financing for Radionetics Oncology. Radionetics Oncology, a clinical stage pharmaceutical company spun out of Crinetics (Nasdaq: CRNX) in 2021, focuses on the discovery and …

13 October 2023

Bayer invests 250 million USD in new cell therapy manufacturing facility in the U.S

Bayer AG has opened a new cell therapy production plant in Berkeley, California, USA, to bring cell therapies to patients on a global scale. The USD 250 million investment will support the production of material required for clinical trials and potential commercial launch of BlueRock Therapeutics’ bemdaneprocel  an in…

06 October 2023

Lotte Biologics to establish three bio plants, boost local employment

Lotte Biologics has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) for the establishment of a Bio Plant in Songdo International City, Incheon, South Korea. Under this land purchase agreement, the company plans to construct three Bio Plants at Block KI20 in Zone 11 (418, 418-9, S…

05 October 2023

Lonza to expand its Biopharmaceutical capacity, generates 180 new jobs

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced an extension of a long-term collaboration with a major global biopharmaceutical partner. The extended agreement will increase the current dedicated bioconjugation capacity fourfold by adding two new bioconjugation…

29 September 2023

HERMES PHARMA announces €25 million investment to bolster capacity

HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has announced it will invest €25 million to further bolster its manufacturing capabilities. The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly gro…

28 September 2023

OBiO launches its state-of-the-art GMP production facility in China

OBiO Technology, a prominent leader in the Cell and Gene Therapy (CGT) field and a Contract Development and Manufacturing Organization, proudly unveiled the official launch of its state-of-the-art GMP production facility, christened as OBiO Intelli-M. The launch of the new base in Shanghai will enhance OBiO's product…

27 September 2023

Besins Healthcare Unveils State-of-the-Art Hormone Factory in Muel

Besins Healthcare, a global lead in Women's and Men's Reproductive Health, today unveiled its novel hormone production facility in Muel, situated near Zaragoza, Spain. This event represents a significant moment in European pharmaceutical history. Built in an astounding time frame since its foundation in mid-2022, thi…

Page 45 of 58